PGGM Investments raised its position in CVS Health Corp (NYSE:CVS) by 15.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,270,407 shares of the pharmacy operator’s stock after buying an additional 172,368 shares during the quarter. PGGM Investments owned 0.12% of CVS Health worth $103,309,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Vanguard Group Inc. grew its holdings in shares of CVS Health by 1.4% during the 2nd quarter. Vanguard Group Inc. now owns 76,557,597 shares of the pharmacy operator’s stock worth $6,159,825,000 after purchasing an additional 1,056,265 shares in the last quarter. FMR LLC grew its holdings in shares of CVS Health by 22.0% during the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after purchasing an additional 5,446,930 shares in the last quarter. Northern Trust Corp boosted its stake in CVS Health by 5.5% in the second quarter. Northern Trust Corp now owns 15,618,081 shares of the pharmacy operator’s stock valued at $1,256,631,000 after buying an additional 807,639 shares in the last quarter. Nordea Investment Management AB boosted its stake in CVS Health by 8.4% in the second quarter. Nordea Investment Management AB now owns 14,154,922 shares of the pharmacy operator’s stock valued at $1,138,905,000 after buying an additional 1,100,373 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in CVS Health by 5.4% in the second quarter. Dimensional Fund Advisors LP now owns 10,426,282 shares of the pharmacy operator’s stock valued at $838,895,000 after buying an additional 534,314 shares in the last quarter. 82.24% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts recently weighed in on the company. Jefferies Group set a $76.00 price objective on CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Loop Capital set a $73.00 price objective on CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Robert W. Baird set a $77.00 price objective on CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Leerink Swann set a $85.00 price objective on CVS Health and gave the company a “buy” rating in a research note on Monday, December 4th. Finally, Citigroup set a $76.00 price objective on CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $86.35.

CVS Health Corp (NYSE CVS) opened at $73.08 on Monday. CVS Health Corp has a 1 year low of $66.45 and a 1 year high of $84.72. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. The stock has a market capitalization of $74,029.46, a PE ratio of 12.80, a PEG ratio of 1.37 and a beta of 0.89.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. The company had revenue of $46.18 billion during the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The firm’s revenue was up 3.5% compared to the same quarter last year. During the same period last year, the company earned $1.64 earnings per share. research analysts predict that CVS Health Corp will post 5.9 EPS for the current fiscal year.

In other CVS Health news, EVP Thomas M. Moriarty sold 20,547 shares of CVS Health stock in a transaction that occurred on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total value of $1,667,799.99. Following the completion of the sale, the executive vice president now directly owns 43,178 shares in the company, valued at $3,504,758.26. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.61% of the company’s stock.

WARNING: This piece of content was reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.watchlistnews.com/pggm-investments-raises-holdings-in-cvs-health-corp-cvs/1770906.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.